These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10408707)

  • 41. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
    Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma.
    Kibel AS; Faith DA; Bova GS; Isaacs WB
    J Urol; 2000 Jul; 164(1):192-6. PubMed ID: 10840458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.
    Valeri A; Fromont G; Sakr W; Azzouzi R; Dey J; Chantrel-Groussard K; Latil A; Berthon P; Cussenot O; Pontes JE; Cher ML
    Urol Oncol; 2005; 23(2):87-92. PubMed ID: 15869992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.
    Driouch K; Dorion-Bonnet F; Briffod M; Champéme MH; Longy M; Lidereau R
    Genes Chromosomes Cancer; 1997 Jul; 19(3):185-91. PubMed ID: 9219000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
    Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
    Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
    Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Loss of heterozygosity on chromosome 10 is associated with bone metastasis of human prostate cancer].
    Hou Z; Luo Y; Jiang YG; Li MC; Lin YH; Zhang YP
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):879-83. PubMed ID: 19157094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor.
    Mason JE; Goodfellow PJ; Grundy PE; Skinner MA
    J Pediatr Surg; 2000 Jun; 35(6):891-6; discussion 896-7. PubMed ID: 10873032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Br J Cancer; 1998 Nov; 78(9):1181-7. PubMed ID: 9820177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
    Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
    Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.